Health Condition 1: B999- Unspecified infectious disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The study includes patients admitted to Paediatric ICU with Gram-negative infections, aged between 28 days and 18 years, and patients with a creatinine clearance (ClCr) above 50mL/min and receiving antibiotics Inj. Ceftriaxone and Inj. Amikacin either alone or in combinations for over 48 hours
Exclusion criteria
Exclusion criteria: The patients undergoing treatment with extracorporeal membrane oxygenation (ECMO) or renal replacement therapy (RRT).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A prognostic model will be developed for predicting outcome of pediatric patients with Gram-negative infectionsTimepoint: 3 years | — |
Secondary
| Measure | Time frame |
|---|---|
| Estimated serum antibiotic levels and antibiotic susceptibility profiles correlating with clinical outcomes, will help clinicians optimise antibiotic regimens for pediatric patients.Timepoint: 3 years | — |
Countries
India
Contacts
Manipal College of Pharmaceutical Sciences